Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage

被引:13
|
作者
Nagamachi, Seiji [1 ]
Ohsawa, Isao [1 ]
Suzuki, Hiyori [1 ]
Sato, Nobuyuki [1 ]
Inoshita, Hiroyuki [1 ]
Hisada, Atsuko [1 ]
Honda, Daisuke [1 ]
Shimamoto, Mamiko [1 ]
Shimizu, Yoshio [1 ]
Horikoshi, Satoshi [1 ]
Tomino, Yasuhiko [1 ]
机构
[1] Juntendo Univ, Fac Med, Dept Internadl Med, Div Nephrol, Tokyo, Japan
关键词
ALTERNATIVE PATHWAY; IGA NEPHROPATHY; ACTIVATION; CELLS; BINDING; EXCRETION; SURFACES; DISEASE; KIDNEY; INJURY;
D O I
10.1186/1471-2369-15-82
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Urinary (U)-complement components have been detected in patients with proteinuric renal diseases, and complement activation via the alternative pathway (AP) is believed to play a role in renal tubular damage. The present study aimed to examine the regulation of complement AP activation in patients with renal tubular damage by focusing on the balance between properdin (P) and factor H (fH). Methods: In the in vivo studies, U concentrations of P, fH and membrane attack complex (MAC) were measured in patients with renal diseases using an enzyme-linked immunosorbent assay (ELISA), and their relationships with the clinical data were evaluated. In the in vitro studies, human proximal tubular epithelial cells (PTECs) were incubated with normal human serum (NHS), P-depleted serum (PDS), purified P and/or fH. Changes in cell morphology and phenotype were assessed by microscopy, real-time polymerase chain reaction (PCR), immunostaining and a cell viability assay. Results: The U-P, fH and MAC concentrations were significantly higher in patients with renal disease than in normal controls and correlated with the U-protein and tubular damage markers. Furthermore, multivariate analysis revealed a relationship between P levels and tubular damage markers. There were no significant changes in morphology and mRNA expression in the AP components (P, fH, fB, C3, C5 and C9) after the addition of up to 25% NHS. Dose-dependent depositions of P or fH were observed after the addition of P or fH on PTECs. Depositions of P were not inhibited by fH in a mixture of a fixed concentration of P and a variable concentration of fH, and vice versa. Preincubation with the fixed concentration of P before the addition of NHS or PDS increased the depositions of P, C3 and MAC compared with incubation with intact NHS or intact PDS only; the depositions of C3 and MAC showed a serum-dependent trend. Preincubation with P before NHS addition significantly suppressed cell viability without causing morphological changes. Conclusions: In the pathogenesis of renal tubular damage, P can directly bind to PTECs and may accelerate AP activation by surpassing fH regulation.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [1] Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage
    Seiji Nagamachi
    Isao Ohsawa
    Hiyori Suzuki
    Nobuyuki Sato
    Hiroyuki Inoshita
    Atsuko Hisada
    Daisuke Honda
    Mamiko Shimamoto
    Yoshio Shimizu
    Satoshi Horikoshi
    Yasuhiko Tomino
    BMC Nephrology, 15
  • [2] The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?
    Michels, Marloes A. H. M.
    Volokhina, Elena B.
    van de Kar, Nicole C. A. J.
    van den Heuvel, Lambertus P. W. J.
    PEDIATRIC NEPHROLOGY, 2019, 34 (08) : 1349 - 1367
  • [3] The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?
    Marloes A. H. M. Michels
    Elena B. Volokhina
    Nicole C. A. J. van de Kar
    Lambertus P. W. J. van den Heuvel
    Pediatric Nephrology, 2019, 34 : 1349 - 1367
  • [4] Complement Factor I Variants in Complement-Mediated Renal Diseases
    Zhang, Yuzhou
    Goodfellow, Renee X.
    Ghiringhelli Borsa, Nicolo
    Dunlop, Hannah C.
    Presti, Stephen A.
    Meyer, Nicole C.
    Shao, Dingwu
    Roberts, Sarah M.
    Jones, Michael B.
    Pitcher, Gabriella R.
    Taylor, Amanda O.
    Nester, Carla M.
    Smith, Richard J. H.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Factor H Autoantibodies and Complement-Mediated Diseases
    Zhang, Yuzhou
    Ghiringhelli Borsa, Nicolo
    Shao, Dingwu
    Dopler, Arthur
    Jones, Michael B.
    Meyer, Nicole C.
    Pitcher, Gabriella R.
    Taylor, Amanda O.
    Nester, Carla M.
    Schmidt, Christoph Q.
    Smith, Richard J. H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [6] COMPLEMENT-MEDIATED REGULATION OF TISSUE FACTOR ACTIVITY IN ENDOTHELIUM
    SAADI, S
    HOLZKNECHT, RA
    PATTE, CP
    STERN, DM
    PLATT, JL
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06): : 1807 - 1814
  • [7] Factor H protects stressed but not quiescent glomerular endothelial cells from complement-mediated damage
    Roumenina, Lubka T.
    Frimat, Marie
    Poitou, Caroline
    Malina, Michal
    Bigot, Sylvain
    Dragon-Durey, Marie-Agnes
    Satchell, Simon C.
    Mathieson, Peter W.
    Halbwachs-Mecarelli, Lise
    Fremeaux-Bacchi, Veronique
    MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2219 - 2219
  • [8] Enterococcus faecalis Escapes Complement-Mediated Killing via Recruitment of Complement Factor H
    Ali, Youssif M.
    Sim, Robert B.
    Schwaeble, Wilhelm
    Shaaban, Mona I.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (06): : 1061 - 1070
  • [9] Factor H and Properdin Recognize Different Epitopes on Renal Tubular Epithelial Heparan Sulfate
    Zaferani, Azadeh
    Vives, Romain R.
    van der Pol, Pieter
    Navis, Gerjan J.
    Daha, Mohamed R.
    van Kooten, Cees
    Lortat-Jacob, Hugues
    Seelen, Marc A.
    van den Born, Jacob
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (37) : 31471 - 31481
  • [10] Enhancement of complement-mediated lysis by a peptide derived from SCR 13 of complement factor H
    Stoiber, H
    Ammann, C
    Spruth, M
    Müllauer, B
    Eberhart, A
    Harris, CL
    Huber, CG
    Longhi, R
    Falkensammer, B
    Würzner, R
    Dierich, MP
    IMMUNOBIOLOGY, 2001, 203 (04) : 670 - 686